| Overall survival | Progression-free survival | ||
---|---|---|---|---|
Median | 95% CI | Median | 95% CI | |
LD (cm) | Â | 0.553 | Â | 0.164 |
 < 5.0 | 91.52 | (65.30, 117.73) | 61.31 | (40.24, 82.37) |
 ≥ 5.0 | 70.23 | (53.28, 87.18) | 42.04 | (27.29,56.80) |
EORa | Â | 0.270 | Â | 0.024 |
 GTR | 92.68 | (72.65, 112.72) | 60.66 | (44.89, 76.44) |
 STR | 88.57 | (65.59, 111.55) | 36.73 | (22.60, 50.85) |
Adjuvant therapy | Â | 0.057 | Â | 0.06 |
 With AT | 99.98 | (83.45, 116.53) | 51.46 | (39.09, 63.84) |
 Without AT | 30.38 | (21.14, 39.61) | 22.14 | (10.33, 33.95) |
WHO gradea | Â | 0.254 | Â | 0.017 |
 Grade I | 92.54 | (54.61, 130.48) | 86.00 | (74.12, 97.88) |
 Grade II | – | – | 26.09 | (18.04, 34.14) |
 Grade III | 81.81 | (69.58, 103.04) | 40.46 | (28.46, 52.46) |